跳至主要内容
临床试验/NCT04492215
NCT04492215招募中不适用

Improving the Participation Rate in ColoRectal Cancer Screening by Training General Practitioners in Motivational Interviewing

University Hospital, Brest106 个研究点 分布在 1 个国家目标入组 902 人开始时间: 2021年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
902
试验地点
106
主要终点
Rate of organised colorectal cancer screening at 24 months

研究概览

简要总结

Colorectal cancer is the 2nd leading cause of cancer mortality in France. However this cancer is preventable in the majority of cases by early detection of adenomas.

In France, there is organized colorectal cancer screening, which relies on general practitioners (GPs). Tests delivered by GPs are performed in 89% of cases. However, GPs do not systematically offer the test, for time management and communication reasons. Patients expect their GPs to offer the test and to focus on their expectations. A previous study conducted on GPs showed that training in communication and motivational interviewing increases the number of tests performed by 12.2%.

In order to facilitate the promotion of screening, the investigators would like to develop a training programme for GPs focusing on the application of Motivational Interviewing (MI) techniques to the promotion of colorectal cancer screening.

Motivational Interviewing is a directive, client-centered counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence.

This study is a multicenter trial in general medicine. In this randomized trial the 902 subjects will be included prospectively by the general practitioners (GP) participating in the study.

As a first step, general practitioners who have never participated in Motivational Interviewing training will be recruited and split into 2 groups by randomization, an intervention group and a control group. The interventional group will then undergo a 3 times 2-day training in Motivational Interviewing.

In a second step, the patients will be included by those GP and a self-questionnaire will be send at the inclusion and after 6, 12 and 24 months. The evaluation of the number of tests performed and the analyse of the Health Belief Model (HBM) self-questionnaire will be carried out.

At 24 months, there will be an evaluation of the denial motivation questionnaire for patients who have not participated in organized colorectal cancer screening.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

盲法说明

The study is based on the participation of general practitioners in a training, the test is necessarily open for doctors. However patients will not know if their doctor has received training and will be blinded..

入排标准

年龄范围
50 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • People with an average risk of colorectal cancer (presenting no symptoms or risk factors).
  • People living in Finistère.
  • People aged 50 to 74 who have never participated in organized screening for colorectal cancer.

排除标准

  • Persons without address to receive the Health Belief Model (HBM)questionnaire
  • People who do not fit the organized screening criteria
  • Persons unable to give consent (patients under guardianship, curatorship, non-French speaking, illiterate)

结局指标

主要结局

Rate of organised colorectal cancer screening at 24 months

时间窗: 24 months

The impact of training general practitioners in motivational interviewing on the rate of organised colorectal cancer screening will be assessed by determining whether or not the immunological test proposed as part of organised colorectal cancer screening at 24 months will be carried out.

次要结局

  • Evolution of the self-assessment of life expectancy(Day 0, 6 months, 12 months and 24 months)
  • Identification of denial of the colorectal cancer screening(24 months)
  • Rate of organised colorectal cancer screening at 12 months(12 months)
  • Changes in perceptions of colorectal cancer screening(Day 0, 6 months, 12 months and 24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (106)

Loading locations...

相似试验

General Practitioners and Participation Rate in... | 临床试验